Toxic epidermal necrolysis: retrospective analysis of 21 consecutive cases managed at a tertiary centre

@article{Rajaratnam2010ToxicEN,
  title={Toxic epidermal necrolysis: retrospective analysis of 21 consecutive cases managed at a tertiary centre},
  author={R. Rajaratnam and C. Mann and P. Balasubramaniam and J. Marsden and S. Taibjee and F. Shah and R. Lim and R. Papini and N. Moiemen and H. Lewis},
  journal={Clinical and Experimental Dermatology},
  year={2010},
  volume={35}
}
  • R. Rajaratnam, C. Mann, +7 authors H. Lewis
  • Published 2010
  • Medicine
  • Clinical and Experimental Dermatology
    • Background.  Toxic epidermal necrolysis (TEN) is a rare, severe blistering disease. Outcome data in British patients is limited to case reports or small series. 
    View on Wiley
    ncbi.nlm.nih.gov
    71 Citations
    Highly Influential Citations
    6
    Background Citations
    17
    Methods Citations
    1
    Results Citations
    3
    71 Citations
    Citation Type

    Citation Type

    Stevens–Johnson syndrome and toxic epidermal necrolysis: a 20‐year single‐center experience
    • 25
    Toxic epidermal necrolysis and hemophagocytic lymphohistiocytosis: a case report and literature review
    • 6
    Stevens–Johnson syndrome and toxic epidermal necrolysis in patients with malignancies
    • 19
    Accuracy of SCORTEN to predict the prognosis of Stevens‐Johnson syndrome/toxic epidermal necrolysis: a systematic review and meta‐analysis
    • 6
    Intravenous immunoglobulin in the treatment of Stevens–Johnson syndrome and toxic epidermal necrolysis: a meta‐analysis with meta‐regression of observational studies
    • 68
    Systemic therapies for Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: a SCORTEN‐based systematic review and meta‐analysis
    • 1
    Toxic Epidermal Necrolysis — Do Any Current Treatments Prevent Deaths?
    UK guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016.
    • 89
    Análisis retrospectivo de 23 años de necrólisis epidérmica tóxica en la Unidad de Quemados de Alicante, España
    • PDF
    Microbiological findings and antibacterial therapy in Stevens–Johnson syndrome/toxic epidermal necrolysis patients from a Swedish Burn Center
    • 9
    • Highly Influenced

    References

    SHOWING 1-10 OF 26 REFERENCES
    Renal involvement in toxic epidermal necrolysis.
    • 37
    Clinical manifestations and outcomes in 17 cases of Stevens–Johnson syndrome and toxic epidermal necrolysis
    • 48
    Treatment of toxic epidermal necrolysis with cyclosporin A.
    • 185
    Improved Burn Center Survival of Patients with Toxic Epidermal Necrolysis Managed without Corticosteroids
    • 360
    • PDF
    Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel.
    • 360
    Experience with toxic epidermal necrolysis treated in a burn center.
    • D. Yarbrough
    • Medicine
    • The Journal of burn care & rehabilitation
    • 1996
    • 52
    Toxic epidermal necrolysis: current evidence, practical management and future directions
    • 223
    • PDF
    Intravenous Immunoglobulin Use in Patients with Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome
    • 67
    Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective study on patients included in the prospective EuroSCAR Study.
    • 386
    TOXIC EPIDERMAL NECROLYSIS: AN ERUPTION RESEMBLING SCALDING OF THE SKIN.
    • A. Lyell
    • Medicine
    • The British journal of dermatology
    • 1956
    • 631